Smith & Nephew (MEX:SN1 N) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:SN1 N Smith & Nephew PLC MEX:SN1 N
78 GF Score
Price MXN256.55
GF Value MXN300.69
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Smith & Nephew  (MEX:SN1 N) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Smith & Nephew Cyclically Adjusted PB Ratio Related Terms


Smith & Nephew Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Smith & Nephew's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smith & Nephew Cyclically Adjusted PB Ratio Chart

Smith & Nephew Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.58 1.77 2.24 1.91

Smith & Nephew Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 2.27 1.95 1.92 1.90

MEX:SN1 N vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Smith & Nephew's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Cyclically Adjusted PB Ratio falls into.


MEX:SN1 N
78GF Score
Smith & Nephew PLC MEX:SN1 N
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Smith & Nephew Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Smith & Nephew's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Smith & Nephew's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=111.964/139.9000*139.9000
=111.964

Current CPI (Dec25) = 139.9000.

Smith & Nephew Annual Data

Book Value per Share CPI Adj_Book
201612 93.251 102.200 127.650
201712 104.002 105.000 138.570
201812 109.819 107.100 143.452
201912 111.110 108.500 143.265
202012 120.106 109.400 153.591
202112 129.754 114.700 158.261
202212 117.777 125.300 131.500
202312 101.330 130.500 108.629
202412 125.327 135.100 129.780
202512 111.964 139.900 111.964

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Smith & Nephew (MEX:SN1 N) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of MXN256.55 is trading 14.7% below its estimated GF Value™ of MXN300.69.

Key valuation signals for MEX:SN1 N:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: MXN300.69 vs. price of MXN256.55 (14.7% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the MEX:SN1 N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
78GF Score

Get the complete analysis for MEX:SN1 N

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN256.55
Price
MXN300.69
GF Value